Unlock instant, AI-driven research and patent intelligence for your innovation.
A lung cancer screening kit
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A reagent and technology for lung cancer, applied in the field of lung cancer screening kits, has achieved good clinical application prospects
Active Publication Date: 2018-09-14
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF4 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
There is no report on the relationship between plasma HSP60 and lung cancer
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0021] The relationship between embodiment 1 HSP60 expression level and lung cancer
[0022] The experimental method is as follows:
[0023] 1. Clinical data
[0024] Fifteen patients with early lung cancer and 10 healthy controls were selected. The basic information is as follows:
[0025] Basic Information
lung cancer patients
healthy control
number of people
15
10
age
61.2±12.2
49.5±10.6
male ratio
10(66.7%)
6(60.0%)
[0026] 2. Detection of HSP60 expression level (quantitative detection of HSP60 content)
[0027] Using the AAH-BLG-CUST kit purchased from RayBiotech (article number: AAH-BLG-CUST), the expression level of HSP60 was detected according to the following method:
[0028] 1. Sample dialysis
[0029] Extract blood from lung cancer patients and healthy controls, centrifuge after EDTA anticoagulation (1200rpm, 10min), absorb the supernatant and perform a second centrifugation (3000rpm, 15min), absorb t...
Embodiment 2
[0059] Embodiment 2 Composition and method of use of the kit for detecting the expression level of HSP60 in blood according to the present invention
[0060] 1. The composition of the HSP60 detection kit
[0061] Detection kit (30 persons):
[0062]
[0063] 2. How to use the HSP60 detection kit
[0064] The method of use is as follows:
[0065] 1. Sample dialysis
[0066] Extract blood from lung cancer patients and healthy controls, centrifuge after EDTA anticoagulation (1200rpm, 10min), absorb the supernatant and perform a second centrifugation (3000rpm, 15min), absorb the supernatant after the second centrifugation, namely plasma, as a test Specimens were stored at -80°C after aliquoting.
[0067] Plasma samples were dialyzed using dialysis tubing prior to biotin labeling. 100 μL of samples were taken respectively and added into dialysis tubes, and then dialyzed in 4000 mL of 1×PBS (pH=8) at 4° C. while stirring. The dialysate was changed every 3 hours, and the sam...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a lung cancer screening kit which comprises an optional reagent used for detecting the HSP60 expression level. The invention further discloses application of the reagent for detecting the HSP60 expression level in preparing a reagent for screening lung cancer. The risk of lung cancer of crowds to be examined can be judged when the kit is used for detecting the HSP60 expression level, the kit can be used for clinic lung cancer auxiliary diagnosis, effective basis is provided for patients for adopting relevant treatment measures or decisions, and the clinic application prospect is good.
Description
technical field [0001] The invention relates to a lung cancer screening kit. Background technique [0002] Lung cancer is one of the most common malignant tumors in the world. Its morbidity and mortality are increasing year by year. Currently, the incidence rate ranks first in the world, which seriously threatens human health and life. [0003] The etiology of lung cancer is complex, and it is generally believed that the influencing factors include: ① smoking; ② environmental pollution: such as smog, interior decoration; ③ unhealthy lifestyle: such as poor eating habits, high life pressure; Silicosis, chronic bronchitis; ⑤ Intrinsic factors in the human body: such as family inheritance, decreased immune function, endocrine dysfunction, etc. [0004] At the same time, lung cancer is a disease that is good at hiding. It often shows clinical symptoms when the disease develops to an advanced stage. 70-80% of lung cancer patients are already in the middle or late stage when they...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.